rs377114648
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_021098.3(CACNA1H):c.3970-10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,609,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 intron
NM_021098.3 intron
Scores
2
Splicing: ADA: 0.00006063
2
Clinical Significance
Conservation
PhyloP100: -0.114
Publications
0 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 16-1210573-C-T is Benign according to our data. Variant chr16-1210573-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 529650.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 5 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.3970-10C>T | intron_variant | Intron 19 of 34 | 1 | NM_021098.3 | ENSP00000334198.7 | |||
| CACNA1H | ENST00000569107.6 | c.3970-10C>T | intron_variant | Intron 19 of 33 | 1 | ENSP00000454990.2 | ||||
| CACNA1H | ENST00000711493.1 | c.3970-10C>T | intron_variant | Intron 19 of 33 | ENSP00000518778.1 | |||||
| CACNA1H | ENST00000565831.7 | c.3970-10C>T | intron_variant | Intron 19 of 33 | 1 | ENSP00000455840.1 | ||||
| CACNA1H | ENST00000711450.1 | c.3970-10C>T | intron_variant | Intron 19 of 34 | ENSP00000518762.1 | |||||
| CACNA1H | ENST00000564231.6 | c.3970-10C>T | intron_variant | Intron 19 of 34 | 1 | ENSP00000457555.2 | ||||
| CACNA1H | ENST00000638323.1 | c.3931-10C>T | intron_variant | Intron 19 of 34 | 5 | ENSP00000492267.1 | ||||
| CACNA1H | ENST00000562079.6 | c.3970-10C>T | intron_variant | Intron 19 of 33 | 1 | ENSP00000454581.2 | ||||
| CACNA1H | ENST00000711438.1 | c.3931-10C>T | intron_variant | Intron 19 of 33 | ENSP00000518754.1 | |||||
| CACNA1H | ENST00000711482.1 | c.3970-10C>T | intron_variant | Intron 19 of 35 | ENSP00000518771.1 | |||||
| CACNA1H | ENST00000711485.1 | c.3970-10C>T | intron_variant | Intron 19 of 34 | ENSP00000518774.1 | |||||
| CACNA1H | ENST00000711455.1 | c.3970-10C>T | intron_variant | Intron 19 of 35 | ENSP00000518768.1 | |||||
| CACNA1H | ENST00000711483.1 | c.3970-10C>T | intron_variant | Intron 19 of 34 | ENSP00000518772.1 | |||||
| CACNA1H | ENST00000711456.1 | c.3970-10C>T | intron_variant | Intron 19 of 33 | ENSP00000518769.1 | |||||
| CACNA1H | ENST00000621827.2 | n.3970-10C>T | intron_variant | Intron 19 of 36 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.4020-10C>T | intron_variant | Intron 19 of 33 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.3970-10C>T | intron_variant | Intron 19 of 34 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*1883-10C>T | intron_variant | Intron 19 of 34 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*3417-10C>T | intron_variant | Intron 18 of 33 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.3970-10C>T | intron_variant | Intron 19 of 35 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.3970-10C>T | intron_variant | Intron 19 of 34 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.3970-10C>T | intron_variant | Intron 19 of 35 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.3970-10C>T | intron_variant | Intron 19 of 35 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.3970-10C>T | intron_variant | Intron 19 of 35 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.3970-10C>T | intron_variant | Intron 19 of 34 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.3970-10C>T | intron_variant | Intron 19 of 36 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.3970-10C>T | intron_variant | Intron 19 of 35 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.3970-10C>T | intron_variant | Intron 19 of 34 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152222Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
6
AN:
152222
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000204 AC: 5AN: 245218 AF XY: 0.0000224 show subpopulations
GnomAD2 exomes
AF:
AC:
5
AN:
245218
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1457496Hom.: 0 Cov.: 40 AF XY: 0.0000124 AC XY: 9AN XY: 725152 show subpopulations
GnomAD4 exome
AF:
AC:
17
AN:
1457496
Hom.:
Cov.:
40
AF XY:
AC XY:
9
AN XY:
725152
show subpopulations
African (AFR)
AF:
AC:
2
AN:
33476
American (AMR)
AF:
AC:
0
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26128
East Asian (EAS)
AF:
AC:
0
AN:
39696
South Asian (SAS)
AF:
AC:
6
AN:
86256
European-Finnish (FIN)
AF:
AC:
0
AN:
49372
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
9
AN:
1111774
Other (OTH)
AF:
AC:
0
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74498 show subpopulations
GnomAD4 genome
AF:
AC:
5
AN:
152340
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74498
show subpopulations
African (AFR)
AF:
AC:
2
AN:
41582
American (AMR)
AF:
AC:
0
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68016
Other (OTH)
AF:
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Oct 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.